EDAP TMS S.A. American Depositary Shares (FOCL) Stock

About EDAP TMS S.A. American Depositary Shares

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

EDAP TMS S.A. American Depositary Shares is headquartered in FR.

EDAP TMS S.A. American Depositary Shares (FOCL) stock trades at $4.13 with a market capitalization of $154.61M. The stock is valued at a price-to-earnings (P/E) ratio of -3.97, price-to-book of -48.00, price-to-sales of 2.24. Over the past 52 weeks the stock has ranged between $1.21 and $6.40, and currently trades 35.5% below its 52-week high.

On profitability, EDAP TMS S.A. American Depositary Shares generates a return on equity (ROE) of -289.98%, return on capital employed of -72.12%, an operating margin of -39.32%, a net profit margin of -56.25%.

Official website: www.focalone.com